These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9072702)

  • 21. Prevention of coronary heart disease with pravastatin.
    Davis DR
    N Engl J Med; 1996 May; 334(20):1334; author reply 1335. PubMed ID: 8609958
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fewer myocardial infarcts. Statin therapy is even effective in the elderly].
    MMW Fortschr Med; 2003 Mar; 145(11):58. PubMed ID: 12688200
    [No Abstract]   [Full Text] [Related]  

  • 23. Economic benefit analysis of primary prevention with pravastatin. Modelling economic benefits after such long term treatment is inappropriate.
    Pharoah P
    BMJ; 1998 Apr; 316(7139):1241-2. PubMed ID: 9553009
    [No Abstract]   [Full Text] [Related]  

  • 24. Pravastatin and coronary heart disease.
    Meyer FP
    N Engl J Med; 1999 Apr; 340(14):1115-6; author reply 1116-7. PubMed ID: 10206830
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of coronary heart disease with pravastatin.
    Rogers S
    N Engl J Med; 1996 May; 334(20):1333; author reply 1334-5. PubMed ID: 8609956
    [No Abstract]   [Full Text] [Related]  

  • 26. Economic benefit analysis of primary prevention with pravastatin. Assumptions are methodologically flawed.
    Freemantle N; Mason J
    BMJ; 1998 Apr; 316(7139):1241-2. PubMed ID: 9583930
    [No Abstract]   [Full Text] [Related]  

  • 27. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A new study on hypercholesterolemia. Statin is effective against heart disease].
    Olsson AG
    Lakartidningen; 1996 May; 93(22):2131-3. PubMed ID: 8667843
    [No Abstract]   [Full Text] [Related]  

  • 29. No primary prevention by pravastatin.
    Meyer FP
    Am J Med; 1998 Feb; 104(2):212-3. PubMed ID: 9528746
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term follow-up of the West of Scotland Coronary Prevention Study.
    DeFilippis AP; Bansal S; Blumenthal RS
    N Engl J Med; 2008 Jan; 358(2):194; author reply 194-5. PubMed ID: 18193527
    [No Abstract]   [Full Text] [Related]  

  • 31. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract]   [Full Text] [Related]  

  • 32. In patients with heart disease, is the benefit of lipid-lowering therapy with statins similar in older patients to that in younger patients?
    Adelman A
    J Fam Pract; 2001 Nov; 50(11):924. PubMed ID: 11711002
    [No Abstract]   [Full Text] [Related]  

  • 33. [One year after WOSCOP, what is the correct pharmacological treatment of primary hypercholesterolemia? Réflexions du Groupe de Pharmacologie Clinique de la Société Française de Cardiologie].
    Therapie; 1996; 51(6):611-4. PubMed ID: 9163995
    [No Abstract]   [Full Text] [Related]  

  • 34. Primary prevention of coronary artery disease.
    Domanski MJ
    N Engl J Med; 2007 Oct; 357(15):1543-5. PubMed ID: 17928603
    [No Abstract]   [Full Text] [Related]  

  • 35. Reduction of coronary events by pravastatin--is lowering low-density lipoprotein cholesterol the answer?
    Halle M; Bery A; Keul J
    Am J Cardiol; 1997 Sep; 80(5):683. PubMed ID: 9295011
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical significance of pravastatin study results.
    Diosy A
    CMAJ; 1996 Aug; 155(4):369-70. PubMed ID: 8752058
    [No Abstract]   [Full Text] [Related]  

  • 37. [A break-through in infarct prevention. WOS (West-of-Scotland)-study confirms effectiveness of early intervention using Pravastin].
    Fortschr Med Suppl; 1996; 172():1-12. PubMed ID: 9022408
    [No Abstract]   [Full Text] [Related]  

  • 38. Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels.
    Tsevat J; Kuntz KM; Orav EJ; Weinstein MC; Sacks FM; Goldman L
    Am Heart J; 2001 May; 141(5):727-34. PubMed ID: 11320359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PRINCE's prospects: statins, inflammation, and coronary risk.
    Azar RR; Waters DD
    Am Heart J; 2001 Jun; 141(6):881-3. PubMed ID: 11376298
    [No Abstract]   [Full Text] [Related]  

  • 40. [Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].
    Sudhop T; von Bergmann K
    MMW Fortschr Med; 2003 May; 145(21):19. PubMed ID: 12845862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.